Singapore markets closed
Straits Times Index
3,314.05 +0.57 (+0.02%) S&P 500
5,324.09 +20.82 (+0.39%) Dow
40,069.36 +65.77 (+0.16%) Nasdaq
16,799.28 +113.31 (+0.68%) Bitcoin USD
67,219.00 +273.35 (+0.41%) CMC Crypto 200
1,370.31 +15.89 (+1.17%)
NVO Sep 2024 150.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:49PM EDT. Market open.
Loading interactive chart…
- Zacks
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen
Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen are included in this Analyst Blog.
- Zacks
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
Bayer (BAYRY) releases Q1 results. J&J (JNJ) set to acquire private biotech, Proteologix, which will add atopic dermatitis candidates.
- GlobeNewswire
Novo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 17 May 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the programme initiate
© 2024 Yahoo. All rights reserved.